Hakan Bjorklund - QIAGEN NV Independent Chairman of the Supervisory Board
| QIA Stock | EUR 43.86 0.19 0.44% |
Chairman
Dr. Hakan Bjorklund has served as Independent Chairman of the Supervisory Board of Qiagen N.V. since June 2018. He served as Independent Member of the Supervisory Board of the Company between March 2017 and June 2018. He is Member of the Compensation Committee, and Chairman of the Selection and Appointment Committee of the Company. Dr. Bjorklund brings an international background in the life science industry to QIAGEN, in particular through his current role as Operating Executive at Avista Capital Partners, as well as through previous roles as CEO of the global pharmaceutical company Nycomed, Regional Director at Astra and President of Astra Draco. Under Mr. Bjorklunds leadership, Nycomed grew from a predominantly Scandinavian business into a global pharmaceutical company. In addition to QIAGEN, he currently serves as Chairman of the Board of Directors at Acino International AG, Swedish Orphan Biovitrum AB and Trimb Healthcare AB since 2018.
| Age | 62 |
| Tenure | 6 years |
| Professional Marks | Ph.D |
QIAGEN NV Leadership Team
Elected by the shareholders, the QIAGEN NV's board of directors comprises two types of representatives: QIAGEN NV inside directors who are chosen from within the company, and outside directors, selected externally and held independent of QIAGEN. The board's role is to monitor QIAGEN NV's management team and ensure that shareholders' interests are well served. QIAGEN NV's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, QIAGEN NV's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Metin Colpan, Independent Member of the Supervisory Board | ||
| Stephane Bancel, Independent Member of the Supervisory Board | ||
| Hakan Bjorklund, Independent Chairman of the Supervisory Board | ||
| Thierry Bernard, Chief Executive Officer, Senior Vice President - Molecular Diagnostics Business Area, Member of the Executive Committee | ||
| Toralf Haag, Member of the Supervisory Board | ||
| Elaine Mardis, Independent Member of the Supervisory Board | ||
| Ross Levine, Independent Member of the Supervisory Board | ||
| Thomas Ebeling, Member of the Supervisory Board | ||
| Roland Sackers, Managing Director, Chief Financial Officer, Member of the Executive Committee | ||
| Elizabeth Tallett, Independent Member of the Supervisory Board | ||
| Lawrence Rosen, Independent Chairman of the Supervisory Board |
QIAGEN Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is QIAGEN NV a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Current Valuation | 11.01 B | |||
| Price To Book | 3.38 X | |||
| Price To Sales | 5.11 X | |||
| Revenue | 2.14 B | |||
| EBITDA | 779.36 M | |||
| Net Income | 423.21 M | |||
| Total Debt | 1.47 B | |||
| Cash Flow From Operations | 715.26 M | |||
| Price To Earnings To Growth | 8.39 X | |||
| Number Of Employees | 22 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in QIAGEN Stock
When determining whether QIAGEN NV offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of QIAGEN NV's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Qiagen Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Qiagen Nv Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in QIAGEN NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade QIAGEN Stock refer to our How to Trade QIAGEN Stock guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.